Previous studies showed that IFN-α has anti-angiogenic properties in various tumors such as Kaposi's sarcomas [28], infantile hemangiomas [29] and some vascular-rich malignancies, melanoma, renal cell carcinoma and neuroendocrine tumors [30]. This evidence concerns the gene IFNA1 and hereditary clear cell renal cell carcinoma.